These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28710755)

  • 1. Rapid Detection of Bacterial Susceptibility or Resistance to Quinolones.
    Otero F; Santiso R; Tamayo M; Bou G; Gosálvez J; Fernández JL
    Methods Mol Biol; 2017; 1644():95-104. PubMed ID: 28710755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid in situ procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis.
    Santiso R; Tamayo M; Gosálvez J; Bou G; Fernández Mdel C; Fernández JL
    BMC Microbiol; 2011 Aug; 11():191. PubMed ID: 21867549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of plasmid-mediated quinolone resistance in Gram-negative bacteria from a tertiary hospital in Nigeria.
    Ogbolu DO; Alli AO; Anorue MC; Daini OA; Oluwadun A
    Indian J Pathol Microbiol; 2016; 59(3):322-6. PubMed ID: 27510669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of plasmid-mediated quinolone resistance (PMQR) genes among antibiotic-resistant Gram-negative bacteria from patients of the Lithuanian National Cancer Center.
    Miškinytė M; Juškaitė R; Skerniškytė J; Voldemarienė V; Valuckas KP; Kučinskienė ZA; Sužiedėlis K; Sužiedėlienė E
    Infect Dis (Lond); 2019 Jun; 51(6):471-474. PubMed ID: 30907205
    [No Abstract]   [Full Text] [Related]  

  • 5. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic rotation and development of gram-negative antibiotic resistance.
    van Loon HJ; Vriens MR; Fluit AC; Troelstra A; van der Werken C; Verhoef J; Bonten MJ
    Am J Respir Crit Care Med; 2005 Mar; 171(5):480-7. PubMed ID: 15516540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid determined resistance to quinolones in clinical isolates of Gram-negative bacilli.
    Diani OA; Ogbolu DO; Ogunledun A
    Afr J Med Med Sci; 2006 Dec; 35(4):437-41. PubMed ID: 17722809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin.
    Kocsis B; Domokos J; Szabo D
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):34. PubMed ID: 27215369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro selections of resistant strains by quinolones.
    López-Bartolomé O; Avial CR; Picazo JJ; Cabronero MC; Campos E
    J Chemother; 1989 Jul; 1(4 Suppl):371-3. PubMed ID: 16312445
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of Chromosomal DNA Fragmentation by Quinolones in an Isogenic Collection of Escherichia coli with Defined Resistance Mechanisms.
    Rodríguez-Martínez JM; Santiso R; Machuca J; Bou G; Pascual Á; Fernández JL
    Microb Drug Resist; 2016 Jul; 22(5):354-9. PubMed ID: 26890225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apigenin as an anti-quinolone-resistance antibiotic.
    Morimoto Y; Baba T; Sasaki T; Hiramatsu K
    Int J Antimicrob Agents; 2015 Dec; 46(6):666-73. PubMed ID: 26526895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin use and susceptibility of Gram-negative organisms to quinolone and non-quinolone antibiotics.
    Troughton JA; Millar G; Smyth ET; Doherty L; McMullan R
    J Antimicrob Chemother; 2011 Sep; 66(9):2152-8. PubMed ID: 21700624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of quinolone resistance in Aeromonas species isolated from humans, water and eels.
    Alcaide E; Blasco MD; Esteve C
    Res Microbiol; 2010; 161(1):40-5. PubMed ID: 19900538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The worldwide emergence of plasmid-mediated quinolone resistance.
    Robicsek A; Jacoby GA; Hooper DC
    Lancet Infect Dis; 2006 Oct; 6(10):629-40. PubMed ID: 17008172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Detection of Antibiotic Resistance in Gram-Negative Bacteria Through Assessment of Changes in Cellular Morphology.
    Otero F; Santiso R; Tamayo M; Fernández JL; Bou G; Lepe JA; McConnell MJ; Gosálvez J; Cisneros JM
    Microb Drug Resist; 2017 Mar; 23(2):157-162. PubMed ID: 27259183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the antibacterial activity of lomefloxacin with that of other antibiotic/chemotherapeutic agents.
    Cuffini AM; Tullio V; Vaiani G; Carlone NA
    J Chemother; 1989 Jul; 1(4 Suppl):178-81. PubMed ID: 16312358
    [No Abstract]   [Full Text] [Related]  

  • 18. [Molecular mechanisms of quinolone resistance in Aeromonas hydrophilia].
    Fang Y; Pan X; Lin L; Shen J; Yin W; Yao J; Hao G; Xu Y
    Wei Sheng Wu Xue Bao; 2014 Feb; 54(2):174-82. PubMed ID: 24818466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an Intensive Care Unit in Greece.
    Ntagiopoulos PG; Paramythiotou E; Antoniadou A; Giamarellou H; Karabinis A
    Int J Antimicrob Agents; 2007 Oct; 30(4):360-5. PubMed ID: 17629680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of resistance phenotypes in gram-negative bacteria].
    Navarro F; Calvo J; Cantón R; Fernández-Cuenca F; Mirelis B
    Enferm Infecc Microbiol Clin; 2011; 29(7):524-34. PubMed ID: 21696863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.